| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/21/2004 | EP1439231A2 Amino-terminally truncated rantes as chemokine antagonists |
| 07/21/2004 | EP1439230A2 Human transmembrane protein TMP-2 gene |
| 07/21/2004 | EP1439226A2 A nucleic acid antisense sequence to a polynucleotide encoding a polypeptide having heparanese activity |
| 07/21/2004 | EP1439224A2 67 human secreted proteins |
| 07/21/2004 | EP1439193A2 Antibody directed to polypeptide having heparanase activity |
| 07/21/2004 | EP1439190A1 Growth differentiation factor-5 |
| 07/21/2004 | EP1438972A1 Remedy for ischemic heart failure |
| 07/21/2004 | EP1438970A2 Methods for inhibiting HIV associated disease using monoclonal antibodies directed against anti-self cytotoxic t-cells |
| 07/21/2004 | EP1438968A1 Topical compositions containing at least one polypeptide hydrolase with an amidasic activity and /or compounds capable of modulating this activity |
| 07/21/2004 | EP1438967A2 Pharmaceutical compositions of fibrinolytic agent |
| 07/21/2004 | EP1438966A2 Use of depsipeptide and congeners thereof as immunosuppressants for treating an infectious disease, an autoimmune disease, allergic reactions or a hyperproliferative skin disease |
| 07/21/2004 | EP1438955A1 High dose liposomal aerosol formulations |
| 07/21/2004 | EP1438434A2 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 07/21/2004 | EP1438431A2 Methods for diagnosing and treating heart disease |
| 07/21/2004 | EP1438418A2 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 07/21/2004 | EP1438413A2 Traversal of nucleic acid molecules through a fluid space and expression in repair cells |
| 07/21/2004 | EP1438407A1 Obesity related genes expressed at least in the hypotalamus, liver or pancreas |
| 07/21/2004 | EP1438405A1 Use of a double-stranded ribonucleic acid for specifically inhibiting the expression of a given target gene |
| 07/21/2004 | EP1438404A2 Inhibition of specific histone deacetylase isoforms |
| 07/21/2004 | EP1438402A2 Modulators of bone homeostasis identified in a high-throughput screen |
| 07/21/2004 | EP1438393A1 Differentiation of whole bone marrow |
| 07/21/2004 | EP1438389A2 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer |
| 07/21/2004 | EP1438386A2 Transmembrane protein differentially expressed in cancer |
| 07/21/2004 | EP1438338A2 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof |
| 07/21/2004 | EP1438336A2 Compositions of fsh with high sialylation degree and their use for the preparation of medicinaments |
| 07/21/2004 | EP1438334A2 Identification of specific tumor antigens by means of the selection of cdna libraries with sera |
| 07/21/2004 | EP1438330A2 Peptide decoys for the preparation of medicaments that are intended for the prevention or treatment of autoimmune pathologies or problems linked to the appearance of antibodies directed against exogenous proteins |
| 07/21/2004 | EP1438329A1 Biologically active peptides and their use for repairing injured nerves |
| 07/21/2004 | EP1438326A2 Diagnosing, treating, and preventing cancer using cables |
| 07/21/2004 | EP1438310A1 Beta-carbolin derivatives as ptp-inhibitors |
| 07/21/2004 | EP1438299A1 Bifunctional chelating agent for actinium |
| 07/21/2004 | EP1438075A2 Methods and compositions relating to restricted expression lentiviral vectors and their applications |
| 07/21/2004 | EP1438074A2 Adjuvant compositions |
| 07/21/2004 | EP1438070A1 Treating vascular disease by inhibiting toll-like receptor-4 |
| 07/21/2004 | EP1438069A1 Enzyme inhibitors for inactivating allergens |
| 07/21/2004 | EP1438067A1 Autologous growth factor cocktail composition, method of production and use |
| 07/21/2004 | EP1438065A2 An in vivo animal model of chronic arterial occlusion and use of collagenase to facilitate guide wire crossing in chronic arterial occlusions |
| 07/21/2004 | EP1438063A1 Modulation of physiological processes and agents useful for same |
| 07/21/2004 | EP1438062A2 Methods and compositions for treating dermal lesions |
| 07/21/2004 | EP1438061A2 Copolymers for suppression of autoimmune diseases, and methods of use |
| 07/21/2004 | EP1438060A2 Prevention and treatment of restenosis by local administration of drug |
| 07/21/2004 | EP1438054A1 Methods and compositions for treating flaviviruses and pestiviruses using 4'-modified nucleoside |
| 07/21/2004 | EP1438043A2 Method of reducing type 2 diabetes in high risk patients |
| 07/21/2004 | EP1437969A2 Method, instruments, and kit for autologous transplantation |
| 07/21/2004 | EP1437961A2 Methods of suppressing microglial activation |
| 07/21/2004 | EP1352091A4 Compositions and methods enabling a totally internally controlled amplification reaction |
| 07/21/2004 | EP1292608B1 Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses |
| 07/21/2004 | EP1289571B1 Prochelators of radiometal labeled molecules |
| 07/21/2004 | EP1257260B1 Powder formulation for inhalation |
| 07/21/2004 | EP1223958A4 Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions |
| 07/21/2004 | EP1143999B1 Lipoprotein complexes and compositions containing them |
| 07/21/2004 | EP0959904B1 Hybrid compositions for intracellular targeting |
| 07/21/2004 | EP0941329B1 Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (lag-3) |
| 07/21/2004 | EP0815224B1 Receptor activation by gas6 |
| 07/21/2004 | CN1514844A Modified granulocyte colony stimulating factor (G-CSF) with reduced immunogenicity |
| 07/21/2004 | CN1514843A Somatostatin-dopamine chimeric analogs |
| 07/21/2004 | CN1514737A Method of treatment of vascular regeneration |
| 07/21/2004 | CN1514733A Modified erythropoietin (EPO) with reduced immunogenicity |
| 07/21/2004 | CN1513999A New earthworm kinase gene mutant |
| 07/21/2004 | CN1513993A Coding gene sequence of chinese genom cDNA library interleukin 21 and its amino acid sequence of protein |
| 07/21/2004 | CN1513991A Recombination human alkaline fiber forming cell growth factor gene and its nonfusion expression product, production method and application |
| 07/21/2004 | CN1513988A Production method of corn superoxide dismutase multienzyme |
| 07/21/2004 | CN1513878A Antitumour medicine containing recombination bacterial toxin protein complex substance |
| 07/21/2004 | CN1513556A Recombination human Mucl-MBP fusion protein antitumour vaccine and production technology |
| 07/21/2004 | CN1513550A Lozenge containing liver cell growth promoting agent and interferon |
| 07/21/2004 | CN1513549A Polythylene glycol-interferon alpha foreeze dried preparation |
| 07/21/2004 | CN1513548A Recombination human interferon alpha-2b oral adhesive plaster and its making method |
| 07/21/2004 | CN1513547A Stabilizing medicinal agent containing ciliary nerve nutritive factor analogue |
| 07/21/2004 | CN1513546A Transfer factor preparation for venoclysis |
| 07/21/2004 | CN1513481A Method for preparing non-specific immunity activator |
| 07/21/2004 | CN1513444A Medicine for treating metaboic syndrome |
| 07/21/2004 | CN1158387C Chimeric gene encoding antigenic determinants of four proteins of L.INFANTUM |
| 07/21/2004 | CN1158386C Polynucleotides isolated from skin cells and methods for their use |
| 07/21/2004 | CN1158305C Insulin derivatives with increased zinc binding |
| 07/21/2004 | CN1158304C Antibacteria frog skin peptide derivative |
| 07/21/2004 | CN1158106C Application of thymosin alpha 1 in preparation of medicine for curing burn and scald |
| 07/21/2004 | CN1158081C Medicine composition containing active vitamin D compound and its use |
| 07/21/2004 | CN1158070C Immediate release tablet |
| 07/21/2004 | CN1158068C Polyol/oil suspensions for the sustained release of proteins |
| 07/20/2004 | US6765099 Neo-tryptophan |
| 07/20/2004 | US6765088 Immunological detection of prions |
| 07/20/2004 | US6765086 Self-aligning peptides modeled on human elastin and other fibrous proteins |
| 07/20/2004 | US6765085 Polypeptide for use in the amplified propagation of crop plants |
| 07/20/2004 | US6765014 1-Acyl-7-nitroindoline derivatives, their preparation and their use as photocleavable precursors |
| 07/20/2004 | US6764995 Uses as an inhibitor of endothelial cell proliferation, capable of inhibiting angiogenesis and causing tumor regression |
| 07/20/2004 | US6764994 Growth/differential factor of the TGF-B family |
| 07/20/2004 | US6764993 Use of o-vanillin and o-vanillin/trolox combinations |
| 07/20/2004 | US6764845 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith |
| 07/20/2004 | US6764831 Methods and compositions for pain management |
| 07/20/2004 | US6764768 Controlled release composition |
| 07/20/2004 | US6764697 Hydroxyethylcellulose layer allows drug-free period; angina therapy; administering hypotensive agent |
| 07/20/2004 | US6764694 Stable formulations of ACE inhibitors, and methods for preparation thereof |
| 07/20/2004 | US6764693 Free radical quenching composition and a method to increase intracellular and/or extracellular antioxidants |
| 07/20/2004 | US6764683 Stimulation of hematopoiesis in patients undergoing cytotoxic cancer chemotherapy; preventing mucositis; cytoprotection |
| 07/20/2004 | US6764681 Lymphocyte antibodies |
| 07/20/2004 | US6764679 Preferential protein for use in the diagnosis and treatment of cancers; antitumor agents; anticarcinogeneic agents |
| 07/20/2004 | US6764678 Local anesthetic methods and kits |
| 07/20/2004 | US6764675 Herpes simplex virus expressing foreign genes and method for treating cancers therewith |
| 07/20/2004 | CA2286733C Reverse-turn mimetics and methods relating thereto |
| 07/20/2004 | CA2227548C Human monoclonal antibody against hepatitis b virus surface antigen (hbvsag) |